Abdelmoujoud Faris

Fes, Morocco

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Advancing infection therapy: the role of novel menthol-based antimicrobials.

Advancing infection therapy: the role of novel menthol-based antimicrobials.

Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 06, 2026

Development of novel CDK9 and CYP3A4 inhibitors for cancer therapy through field and computational approaches.

Development of novel CDK9 and CYP3A4 inhibitors for cancer therapy through field and computational approaches.

Journal: Frontiers in chemistry
Published: July 30, 2024

Computational insights into rational design and virtual screening of pyrazolopyrimidine derivatives targeting Janus kinase 3 (JAK3).

Computational insights into rational design and virtual screening of pyrazolopyrimidine derivatives targeting Janus kinase 3 (JAK3).

Journal: Frontiers in chemistry
Published: April 29, 2024

3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line.

3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line.

Journal: Frontiers in chemistry
Published: February 10, 2024

QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.

QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.

Journal: Journal of biomolecular structure & dynamics
Published: December 07, 2023

Revealing innovative JAK1 and JAK3 inhibitors: a comprehensive study utilizing QSAR, 3D-Pharmacophore screening, molecular docking, molecular dynamics, and MM/GBSA analyses.

Revealing innovative JAK1 and JAK3 inhibitors: a comprehensive study utilizing QSAR, 3D-Pharmacophore screening, molecular docking, molecular dynamics, and MM/GBSA analyses.

Journal: Frontiers in molecular biosciences
Published: December 02, 2023

Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation.

Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation.

Journal: Anti-cancer drugs
Published: November 29, 2023

Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis.

Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis.

Journal: Molecules (Basel, Switzerland)
Published: October 26, 2023

In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors.

In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors.

Journal: Journal of biomolecular structure & dynamics
Published: October 20, 2023

From himachalenes to trans-himachalol: unveiling bioactivity through hemisynthesis and molecular docking analysis.

From himachalenes to trans-himachalol: unveiling bioactivity through hemisynthesis and molecular docking analysis.

Journal: Scientific reports
Published: September 02, 2023

High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods.

High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods.

Journal: Journal of biomolecular structure & dynamics
Published: August 04, 2023

Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors.

Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors.

Journal: Molecules (Basel, Switzerland)
Published: July 20, 2023
Showing 1-12 of 14

Last Updated: 09/26/2026